deltatrials
Completed OBSERVATIONAL NCT05143333

Cognitive Assessment in COVID-19 Positive Patients Using the DANA App

Cognitive Assessment in COVID Positive Patients Using the DANA App

Sponsor: AnthroTronix, Inc.

Conditions COVID-19
Interventions DANA app
Updated 4 times since 2022 Last updated: Jan 7, 2022 Started: Jul 1, 2021 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19, this trial is completed. The trial is conducted by AnthroTronix, Inc. and has accumulated 4 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshotRecruiting~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Feb 2022 — Jul 2024 [monthly]

    Completed

    Status: RecruitingCompleted

  4. Jan 2022 — Feb 2022 [monthly]

    Recruiting

    First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AnthroTronix, Inc.
  • Johns Hopkins University
Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations